Yanlin Yu

2.3k total citations
35 papers, 1.5k citations indexed

About

Yanlin Yu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Yanlin Yu has authored 35 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 10 papers in Oncology and 9 papers in Immunology. Recurrent topics in Yanlin Yu's work include PI3K/AKT/mTOR signaling in cancer (8 papers), Melanoma and MAPK Pathways (5 papers) and Immunotherapy and Immune Responses (5 papers). Yanlin Yu is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (8 papers), Melanoma and MAPK Pathways (5 papers) and Immunotherapy and Immune Responses (5 papers). Yanlin Yu collaborates with scholars based in United States, China and Hong Kong. Yanlin Yu's co-authors include Glenn Merlino, Lee J. Helman, Chand Khanna, Paul S. Meltzer, Javed Khan, A. Hari Reddi, Timothy J. Triche, Elai Davicioni, Vishwas Paralkar and Benjamin S. Weeks and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and The Journal of Cell Biology.

In The Last Decade

Yanlin Yu

31 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yanlin Yu United States	18	913	377	197	194	192	35	1.5k
Michela Noseda United Kingdom	20	1.6k 1.8×	307 0.8×	327 1.7×	179 0.9×	150 0.8×	33	2.1k
Rebecca Sowers United States	19	801 0.9×	562 1.5×	270 1.4×	460 2.4×	133 0.7×	24	1.5k
Monica Hermanson Sweden	12	635 0.7×	307 0.8×	228 1.2×	135 0.7×	105 0.5×	15	1.2k
Anastasia Sacharidou United States	21	948 1.0×	238 0.6×	263 1.3×	104 0.5×	117 0.6×	36	1.8k
Daisuke Kita Japan	18	459 0.5×	159 0.4×	248 1.3×	196 1.0×	155 0.8×	53	1.1k
Guido Reifenberger Germany	21	1.1k 1.2×	443 1.2×	270 1.4×	173 0.9×	449 2.3×	26	2.1k
Jonathan M. Cooper United States	16	774 0.8×	383 1.0×	193 1.0×	210 1.1×	312 1.6×	18	1.7k
Takuyu Taki Japan	17	654 0.7×	310 0.8×	186 0.9×	124 0.6×	268 1.4×	63	1.3k
Cristina Roca Italy	9	1.4k 1.6×	380 1.0×	436 2.2×	133 0.7×	122 0.6×	9	2.0k
Naoki Maehara Japan	23	780 0.9×	798 2.1×	367 1.9×	174 0.9×	64 0.3×	85	1.8k

Countries citing papers authored by Yanlin Yu

Since Specialization

Citations

This map shows the geographic impact of Yanlin Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanlin Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanlin Yu more than expected).

Fields of papers citing papers by Yanlin Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanlin Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanlin Yu. The network helps show where Yanlin Yu may publish in the future.

Co-authorship network of co-authors of Yanlin Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanlin Yu. A scholar is included among the top collaborators of Yanlin Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanlin Yu. Yanlin Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yu, Yanlin & Mitchell Ho. (2025). CAR NK cell therapy for solid tumors: potential and challenges. PubMed. 8(4). 275–289.

Clements, G, et al.. (2024). Development of Personalized Strategies for Precisely Battling Malignant Melanoma. International Journal of Molecular Sciences. 25(9). 5023–5023. 6 indexed citations

Chen, Weiping, et al.. (2024). Abstract 5524: Identification of PAEP as an immune activity modulator to mediate the immune resistance in tumor metastasis. Cancer Research. 84(6_Supplement). 5524–5524.

Wu, Pei‐Yu, et al.. (2024). Identifying and Validating Extracellular Matrix-Related Gene CTSH in Diabetic Foot Ulcer Using Bioinformatics and Machine Learning. Journal of Inflammation Research. Volume 17. 5871–5887. 4 indexed citations

Hwang, Eunmi, Woo Kyung Lee, Yuelin J. Zhu, et al.. (2023). Thyroid hormone receptor α1: a novel regulator of thyroid cancer cell differentiation. Oncogene. 42(41). 3075–3086. 6 indexed citations

Merlino, Glenn, et al.. (2023). Ez-Metastasizing: The Crucial Roles of Ezrin in Metastasis. Cells. 12(12). 1620–1620. 12 indexed citations

Merlino, Glenn, et al.. (2023). CAR NK Cell Therapy for the Treatment of Metastatic Melanoma: Potential & Prospects. Cells. 12(23). 2750–2750. 5 indexed citations

Yu, Yanlin. (2023). The Function of NK Cells in Tumor Metastasis and NK Cell-Based Immunotherapy. Cancers. 15(8). 2323–2323. 54 indexed citations

Yu, Yanlin, Meng Dai, Liping Huang, et al.. (2023). PTEN phosphatase inhibits metastasis by negatively regulating the Entpd5/IGF1R pathway through ATF6. iScience. 26(2). 106070–106070. 11 indexed citations

10.

Yu, Yanlin, Arnulfo Mendoza, & Glenn Merlino. (2023). Using the single-cell imaging system and orthotropic footpad injection to establish mouse models for experimental and spontaneous melanoma metastasis. STAR Protocols. 4(3). 102349–102349. 2 indexed citations

11.

Wang, Yuyi, Ombretta Salvucci, Hidetaka Ohnuki, et al.. (2021). Targeting the SHP2 phosphatase promotes vascular damage and inhibition of tumor growth. EMBO Molecular Medicine. 13(7). e14089–e14089. 20 indexed citations

12.

Qin, Yifei, Qiang Zuo, Lei Huang, et al.. (2021). PERK mediates resistance to BRAF inhibition in melanoma with impaired PTEN. npj Precision Oncology. 5(1). 68–68. 17 indexed citations

13.

Zuo, Qiang, Liping Huang, Yifei Qin, et al.. (2018). AXL/AKT axis mediated-resistance to BRAF inhibitor depends on PTEN status in melanoma. Oncogene. 37(24). 3275–3289. 76 indexed citations

14.

Threapleton, Diane, Jingbo Lu, Kewei Zhang, et al.. (2016). Identification of novel genes and pathways in carotid atheroma using integrated bioinformatic methods. Scientific Reports. 6(1). 18764–18764. 17 indexed citations

15.

Yu, Yanlin, et al.. (2010). Epigenetic Drugs Can Stimulate Metastasis through Enhanced Expression of the Pro-Metastatic Ezrin Gene. PLoS ONE. 5(9). e12710–e12710. 45 indexed citations

16.

Yan, Jun, Yanlin Yu, Nan Wang, et al.. (2004). LFIRE-1/HFREP-1, a liver-specific gene, is frequently downregulated and has growth suppressor activity in hepatocellular carcinoma. Oncogene. 23(10). 1939–1949. 52 indexed citations

17.

Rozental, Renato, et al.. (2004). Sodium Butyrate Induces Apoptosis in MSN Neuroblastoma Cells in a Calcium Independent Pathway. Neurochemical Research. 29(11). 2125–2134. 9 indexed citations

18.

Yu, Yanlin, Javed Khan, Chand Khanna, et al.. (2004). Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nature Medicine. 10(2). 175–181. 441 indexed citations

19.

Yu, Yanlin & Glenn Merlino. (2002). Constitutive c-Met signaling through a nonautocrine mechanism promotes metastasis in a transgenic transplantation model.. PubMed. 62(10). 2951–6. 54 indexed citations

20.

Ying, Hao, et al.. (2001). Cloning and Characterization of F-LANa, Upregulated in Human Liver Cancer. Biochemical and Biophysical Research Communications. 286(2). 394–400. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact